A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit–positive Acute Myeloid Leukemia

Anjali S. Advani, William Tse, Hong Li, Xuefei Jia, Paul Elson, Brenda Cooper, Francis Ali-Osman, Jino Park, Arati V. Rao, David A. Rizzieri, Eunice S. Wang, Claudiu V. Cotta, Matt Kalaycio, Ronald M. Sobecks, Basel Rouphail, Jaroslaw P. Maciejewski, Jaime Fensterl, Jennifer S. Carew, Bethany Foster, Mary Lynn RushBarbara Tripp, Donna Adams, Donna Corrigan, Elizabeth A. Griffiths, Mikkael A. Sekeres

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint

Dive into the research topics of 'A Phase II Trial of Imatinib Mesylate as Maintenance Therapy for Patients With Newly Diagnosed C-kit–positive Acute Myeloid Leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences